The International Pharmacopoeia (Ph. Int.) - Radiopharmaceuticals
The World Health Organization and the International Atomic Energy Agency (IAEA), a UN specialized agency, have been working jointly on specifications for radiopharmaceuticals since 2001. Both organizations recognize that radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy.
Current advice and guidance concerning regulations governing radioactive materials including those on safe handling and production of radioisotopes can be found on the IAEA website.
The monographs and associated texts listed here have been adopted by the Expert Committee on Specifications for Pharmaceutical Preparations.